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Abstract Although coculture of hematopoietic stem cells
(HSCs) with stromal cells is a useful system to study
hematopoiesis in the niche, little is known regarding the
precise cellular and molecular mechanisms of maintaining
HSCs through cell–cell interactions. The murine preadi-
pose stromal cell line MC3T3-G2/PA6 (PA6) has been
demonstrated to support HSCs in vitro. In this study,
microarray analysis was performed on PA6 cells and HSC-
nonsupporting PA6 subclone cells to identify genes
responsible for supporting HSC activity. Comparison of
gene expression proﬁles revealed that only 144 genes were
down-regulated by more than twofold in PA6 subclone
cells. Of these down-regulated genes, we selected 11 can-
didate genes and evaluated for the maintenance of HSC
function by overexpressing these genes in PA6 subclone
cells. One unknown gene, 1110007F12Rik (also named as
Tmem140), which is predicted to encode an integral
membrane protein, demonstrated a partial restoration of the
defect in HSC-supporting activity.
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1 Introduction
Hematopoietic stem cells (HSCs) are capable of self-
renewal and multilineage differentiation and generate all
types of blood cells throughout the lifetime. A major
challenge for a long time has been the establishment of
culture conditions that can facilitate ex vivo expansion of
HSCs. To date, a large number of attempts using combi-
nations of multiple cytokines have resulted in limited
success, with a several-fold increase in HSC numbers
under the optimal culture conditions [1, 2]. A major
problem is that culture conditions established thus far have
induced HSC proliferation coupled with differentiation,
leading to a progressive loss of in vivo long-term repopu-
lating potential [3–8]. Therefore, a better understanding of
mechanisms that regulate HSC self-renewal and differen-
tiation is required to achieve ex vivo expansion of HSCs.
In the adult bone marrow, HSCs are thought to reside in
a speciﬁc microenvironment, referred to as the niche,
which is composed of stromal cells that play a vital role in
determining stem cell fate. Indeed, several stromal cell
lines have been established not only from bone marrow but
also from fetal liver and the aorta-gonad-mesonephros
region and have been shown to maintain HSCs in vitro [9–
16]. Coculture of HSCs with stromal cell lines is a useful
system to study hematopoiesis in the niche. Although
physical contact between HSCs and stromal cell lines has
been demonstrated to be essential, little is known regarding
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MC3T3-G2/PA6 (PA6) is a preadipose stromal cell line
derived from newborn mouse calvaria that can support
long-term hematopoiesis in vitro [17]. In addition, PA6
subclones incapable of supporting the proliferation of
HSCs have been isolated [18]. It has also been shown that
the hematopoiesis-supporting ability of PA6 cells is not
solely conferred by their expression of c-kit ligand, stem
cell factor (SCF). In this study, microarray analysis was
performed to identify genes responsible for supporting
HSC activity of PA6 cells. Eleven genes speciﬁcally down-
regulated in the subclone cells were selected and charac-
terized by overexpressing the corresponding cDNAs in the
subclone cells.
2 Materials and methods
2.1 Mice
C57BL/6 (B6-Ly5.2) mice were purchased from Charles
River Laboratories Japan (Yokohama, Japan). C57BL/6
mice congenic for the Ly5 locus (B6-Ly5.1) were obtained
from RIKEN BRC. B6-Ly5.1/Ly5.2 F1 mice were obtained
from mating pairs of B6-Ly5.1 and B6-Ly5.2 mice. All
animal experiments were approved by the Animal Exper-
iment Committee of the RIKEN Tsukuba Institute.
2.2 Stromal cell culture and lentiviral transduction
The OP9 stromal cell line was obtained from RIKEN BRC
Cell Bank. PA6 and OP9 cells were maintained in Mini-
mum Essential Medium Eagle-a (MEM-a) (Sigma-Aldrich,
St Louis, MO) containing 20% fetal bovine serum (FBS)
(Sigma-Aldrich) at 37C in a 5% CO2 atmosphere. FAN-
TOM cDNA clones (kindly provided by Dr. Y. Hayashizaki
and Dr. J. Kawai, RIKEN GSC) corresponding to the genes
used in this study were subcloned into the lentiviral vector
plasmid pCSII-EF-MCS-IRES2-Venus. Recombinant len-
tiviral vectors were produced as described previously [19].
PA6 subclone cells were transduced with lentiviral vectors
expressing cDNAs at a multiplicity of infection of 200 and
[90% of transduction efﬁciency was conﬁrmed by ﬂuo-
rescence-activated cell sorting (FACS) analysis for Venus
expression.
2.3 Puriﬁcation of CD34
-KSL cells and coculture
with stromal cells
CD34
-/lowc-Kit
+Sca-1
+lineage marker
- (CD34
-KSL)
cells were puriﬁed as described previously with minor
modiﬁcations [20]. Brieﬂy, bone marrow cells isolated
from 10- to 16-week-old B6-Ly5.2 mice were stained with
a lineage marker antibody cocktail consisting of biotinyl-
ated anti-Gr-1, anti-Mac-1, anti-B220, anti-IgM, anti-CD4,
anti-CD8, and anti-Ter119 antibodies (eBioscience, San
Diego, CA). Lineage marker
+ cells were depleted using
streptavidin-coupled Dynabeads M-280 (Invitrogen,
Carlsbad, CA). The remaining cells were stained with
ﬂuorescein isothiocyanate (FITC)-conjugated anti-CD34,
phycoerythrin (PE)-conjugated anti-Sca-1, and allophyco-
cyanin (APC)-conjugated anti-c-Kit antibodies (all from
BD Biosciences, San Jose, CA). The biotinylated anti-
bodies were developed with streptavidin-APC-Cy7 (BD
Biosciences). FACS was performed with a FACSVantage
SE (BD Biosciences). CD34
-KSL cells were sorted into
individual wells of a 96-well plate containing stromal cells
(1 9 10
4 cells/well) irradiated with 1.5 Gy and were
cocultured in 150 lL of MEM-a containing 20% FBS.
2.4 Colony-forming cell assay
After 10 days of coculture, CD34
-KSL HSCs were col-
lected and plated in a 12-well plate containing 0.6 mL of
methylcellulose medium (MethoCult GF M3434) (Stem-
Cell Technologies, Vancouver, Canada) containing 50 ng/
mL rmSCF, 10 ng/mL rmIL-3, 10 ng/mL rhIL-6, and
3 units/mL rhEPO. After 12 days of incubation, colonies
were recovered, cytospun onto glass slides, and then sub-
jected to Hemacolor (Merck KGaA, Darmstadt, Germany)
staining for morphological examination. Colony-forming
unit-granulocyte, erythrocyte, monocyte, megakaryocyte
(CFU-GEMM), CFU-granulocyte, erythrocyte, monocyte
(CFU-GEM), CFU-granulocyte, monocyte (CFU-GM),
CFU-granulocyte (CFU-G), CFU-monocyte (CFU-M), and
burst forming unit-erythrocyte (BFU-E) were scored using
standard scoring criteria. The total colony number was
expressed as colony-forming cell (CFC).
2.5 Competitive repopulation assay
The competitive repopulation assay was performed by
using the congenic Ly5 mouse system as described previ-
ously [8]. CD34
-KSL HSCs after coculture were mixed
with 2 9 10
5 total bone marrow competitor cells from B6-
Ly5.1 mice and transplanted into lethally (9.5 Gy) irradi-
ated B6-Ly5.1 mice. At 12 to 16 weeks after
transplantation, peripheral blood cells of the recipient mice
were collected by retro-orbital bleeding. After lysis of red
blood cells with ammonium chloride buffer, the remaining
nucleated cells were stained with FITC-conjugated anti-
Ly5.2, PE-conjugated anti-Ly5.1, biotinylated anti-Mac1,
and biotinylated anti-Gr1 antibodies, followed by addition
of streptavidin-PerCP. The cells were stained simulta-
neously with APC-conjugated anti-B220 antibody or a
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123mixture of APC-conjugated anti-CD4 and anti-CD8 anti-
bodies. FACS analysis was performed with a
FACSCalibur. Donor chimerism was determined as the
percentage of Ly5.2
+ cells. When the percent chimerism
was[1.0% for all myeloid, B-lymphoid, and T-lymphoid
lineages, recipient mice were considered to be multilineage
reconstituted.
2.6 Microarray analysis
Total RNA was isolated from stromal cells using the IS-
OGEN reagent (Nippon Gene, Tokyo, Japan) and puriﬁed
with the RNeasy MinElute cleanup kit (Qiagen, Hilden,
Germany). Biotin-labeled cRNA was prepared from 1 lg
of the puriﬁed total RNA with a one-cycle cDNA synthesis
kit and 30-ampliﬁcation reagents for IVT labeling (Af-
fymetrix, Santa Clara, CA) and was hybridized to an
Affymetrix Gene Chip Mouse Genome 430 2.0 array
(Affymetrix), which contains approximately 45,000 probe
sets for analyzing the expression levels of more than
34,000 mouse genes. After washing and staining with the
antibody ampliﬁcation procedure, the microarrays were
scanned with an Affymetrix GeneChip Scanner 3000 7G.
All these procedures were carried out according to the
manufacturer’s instructions. The expression value (Signal)
and detection call (Present (P), Absent (A), or Marginal
(M)) for each probe set were calculated using GeneChip
Operating Software version 1.4 (Affymetrix). The Signal
values were normalized so that their mean in each exper-
iment was 100 in order to adjust for minor differences
between the experiments. The change value (Signal Log
Ratio) and change call (Increase, Marginal Increase, No
Change, Marginal Decrease, or Decrease) for each probe
set were calculated by Comparison Analysis of the
software. All experiments were performed in duplicate
using two independent cell samples. To identify differen-
tially expressed genes, we selected probe sets that showed a
change call of Decrease and a Signal Log Ratio value of
B–1 (more than twofold down-regulation) or a change call
of Increase and a Signal Log Ratio value of C1 (more than
twofold up-regulation) in each of the two independent
experiments.
2.7 Quantitative real-time polymerase chain reaction
Total RNA was isolated from stromal cells using the IS-
OGEN reagent, and cDNA was synthesized from 1 lgo f
total RNA using SuperScript II reverse transcriptase
(Invitrogen). Real-time polymerase chain reaction (PCR)
ampliﬁcation with two independent cell samples was car-
ried out using the LightCycler FastStart DNA Master
SYBR Green I kit (Roche, Penzberg, Germany) according
to the manufacturer’s instructions. The primer sets used in
this study are listed in Table 1. Data were normalized
GAPDH mRNA levels. Gene-speciﬁc ampliﬁcation was
conﬁrmed by determining the melting curves of the PCR
products and by a single band of the expected size in
agarose gel electrophoresis.
3 Results and discussion
3.1 Subclones of the PA6 cell line are defective
in supporting HSCs
Although PA6 subclones 2, 12, and 14 have been isolated
in terms of inability to support long-term hematopoiesis in
vitro, their HSC-supporting capacity has not been precisely
Table 1 Primers used in
quantitative real-time PCR
Gene Primer sequence Product size (bp)
1110007F12Rik Forward 50-GCCCTGTGCCTGATGTTCTAC-30 111
Reverse 50-GCCCATGTCCTCCTTCCAC-30
2900064A13Rik Forward 50-GTTTGACCCTGTCCGAGTCG-30 205
Reverse 50-CGGGAGAACCATCATCATAACC-30
Ccl2 Forward 50-TTAAAAACCTGGATCGGAACCAA-30 121
Reverse 50-GCATTAGCTTCAGATTTACGGGT-30
Ccl9 Forward 50-TCAGATTGCTGCCTGTCCTAT-30 117
Reverse 50-GAACCCCCTCTTGCTGATAAAG-30
Cxcl5 Forward 50-TGCGTTGTGTTTGCTTAACCG-30 107
Reverse 50-AGCTATGACTTCCACCGTAGG-30
IL-1rn Forward 50-GCTCATTGCTGGGTACTTACAA-30 132
Reverse 50-CCAGACTTGGCACAAGACAGG-30
IL-6 Forward 50-TAGTCCTTCCTACCCCAATTTCC-30 76
Reverse 50-TTGGTCCTTAGCCACTCCTTC-30
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123assessed [18]. Therefore, we evaluated the maintenance of
HSC function after coculture with PA6 subclones 2 and 12
(hereinafter referred to as S-2 and S-12, respectively) by in
vitro CFC and in vivo competitive repopulation assays
using CD34
-KSL cells as highly puriﬁed HSCs [20].
Murine bone marrow-derived OP9 stromal cell line that
can support HSCs was also used as a control [13]. As
shown in Table 2, the CFC frequency signiﬁcantly
decreased after 10 days of coculture with PA6 S-2 and S-
12 cells compared with PA6 cells, and lower levels of
engraftment were observed in transplanted mice. These
results indicate that PA6 subclone cells have a substantial
defect in supporting HSCs even after short-term coculture.
3.2 Identiﬁcation of genes that were speciﬁcally
down-regulated in PA6 subclone cells
We hypothesized that genes responsible for supporting
HSCs would be down-regulated in PA6 subclone cells. To
identify genes speciﬁcally down-regulated in PA6 subclone
cells, microarray analysis was performed on PA6 cells,
PA6 S-2 and S-12 cells, and OP9 cells using an Affymetrix
GeneChip array containing approximately 45,000 probe
sets representing over 34,000 mouse genes. As expected,
gene expression proﬁling showed a few differences in gene
expression between PA6 cells and PA6 subclone cells.
Compared to PA6 cells, only 144 genes were down-regu-
lated by more than twofold in both PA6 subclone cells. Of
these down-regulated genes, 41 genes were of unknown
function, and 67 of 103 (65%) known genes encoded
Table 2 CFC frequency and competitive repopulation capacity
Stromal
cells
CFC
frequency
No. of reconstituted
mice (%)
% Chimerism
PA6 10.8 ± 7.51 6/9 (66.7) 13.2 ± 19.9
PA6 S-2 0.60 ± 0.97* 4/10 (40.0) 4.5 ± 11.2**
PA6 S-12 3.2 ± 3.05* 3/8 (37.5) 3.4 ± 5.9**
OP9 28.2 ± 6.61 5/9 (55.6) 8.6 ± 11.5
A total of 80 CD34
-KSL HSCs (10 cells/well) were cocultured with
stromal cells for 10 days and were then subjected to the CFC assay.
The CFC frequency represents the colony number per ten input
CD34
-KSL HSCs. For the competitive repopulation assay, 30
CD34
-KSL HSCs were cocultured with stromal cells for 10 days and
then transplanted into lethally irradiated mice. At 12 weeks after
transplantation, peripheral blood cells of the recipient mice were
analyzed. Data represent the mean ± SD of two independent
experiments
*P\0.01, **P[0.2 versus PA6, Student’s t-test
Table 3 List of candidate genes down-regulated in PA6 subclone cells compared with PA6 cells
Gene symbol Gene title Refseq ID Microarray qPCR
vs. PA6 vs. OP9 vs. PA6 vs. OP9
PA6
S-2
PA6
S-12
PA6
S-2
PA6
S-12
PA6
S-2
PA6
S-12
PA6
S-2
PA6
S-12
1110007F12Rik RIKEN cDNA 1110007F12
gene
NM_197986 0.30 0.46 0.11 0.19 0.29 0.23 0.16 0.13
1200009O22Rik RIKEN cDNA 1200009O22
gene
NM_025817 0.30 0.21 2.79 1.48 ND ND ND ND
2900064A13Rik RIKEN cDNA 2900064A13
gene
NM_133749 0.41 0.37 1.23 1.16 0.29 0.33 0.48 0.55
Ccl2 Chemokine (C-C motif)
ligand 2
NM_011333 0.09 0.13 0.04 0.06 0.16 0.07 0.09 0.04
Ccl9 Chemokine (C-C motif)
ligand 9
NM_011338 0.14 0.19 0.03 0.04 0.10 0.09 0.04 0.03
Cd53 CD53 antigen NM_007651 0.23 0.15 0.28 0.14 ND ND ND ND
Cxcl5 Chemokine (C-X-C motif)
ligand 5
NM_009141 0.33 0.23 0.43 0.38 0.20 0.13 0.90 0.60
Hgf Hepatocyte growth factor NM_010427 0.41 0.41 0.85 0.88 ND ND ND ND
Il1rn(IL-1rn) Interleukin 1 receptor
antagonist
NM_031167 0.09 0.12 0.26 0.31 \0.03 0.04 \1.25 1.45
Il6(IL-6) Interleukin 6 NM_031168 0.38 0.44 2.07 2.62 0.30 0.16 2.42 1.31
Ppap2b Phosphatidic acid phosphatase
type 2B
NM_080555 0.22 0.22 0.09 0.09 ND ND ND ND
Relative expression levels in PA6 subclone cells (S-2 and S-14) compared with PA6 and OP9 cells were calculated using data from microarray
and quantitative real-time PCR (qPCR) analyses. Data represent the average of fold changes from two independent experiments
ND not determined
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123membrane and extracellular space proteins according to the
Gene Ontology cellular component classiﬁcation. On the
other hand, 121 genes were up-regulated by more than
twofold and 30 of 67 (45%) known genes encoded mem-
brane and extracellular space proteins. The signal values
and detection calls for this analysis are provided in sup-
plemental data. Among the down-regulated genes, eight
genes of known/predicted function including chemokine-
and cytokine-related genes, which were expected to effect
on the HSC-supporting activity, and three genes of
unknown function, which were predicted to encode mem-
brane proteins, were selected for further analysis (Table 3).
3.3 Characterization of candidate genes
To determine the requirement of candidate genes for the
supportive activity of PA6 cells, PA6 S-2 cells were
transduced with lentiviral vectors containing the corre-
sponding cDNAs. In all experiments, the transduction
efﬁciency was more than 90% as determined by FACS
analysis for Venus-positive cells. CD34
-KSL HSCs were
cocultured with PA6 S-2 cells expressing candidate genes
for 10 days and then subjected to the CFC assay. As shown
in Fig. 1, the CFC frequency increased when cocultured
with PA6 S-2 cells overexpressing the candidate genes
except Hgf compared with PA6 S-2 cells. Morphological
evaluation of the colonies revealed that the number of
CFU-GEMM, which is the most primitive colony type
observed in the CFC assay, increased except Ccl2 and
Ccl9. Of note, although the overexpression of IL-6
increased the number of colonies to the same level as PA6
cells, a large proportion (*80%) of colonies were CFU-M.
We next performed the competitive repopulation assayto
determine the effect of overexpressing seven candidate
genes including Ccl9, IL-6, Ppap2b, and Cxcl5, and three
unknown genes. As shown in Table 4, successful multilin-
eage reconstitution was observed in all mice transplanted
with HSCs cocultured with PA6 S-2 cells overexpressing
Fig. 1 Effect of over expression of candidate genes on the CFC
frequency. A total of 80 CD34
-KSL HSCs (10 cells/well) were
cocultured with PA6 cells, PA6 S-2 cells, or PA6 S-2 cells expressing
the indicated genes for 10 days and then subjected to the CFC assay.
Individual colonies were scored according to their morphology. Data
represent the average of two independent experiments
Table 4 Effect of overexpression of candidate genes on the competitive repopulation capacity
No. of reconstituted mice (%) % Chimerism
Total Myeloid B-lymphoid T-lymphoid
PA6 9/9 (100) 22.1 ± 25.1 30.9 ± 30.9 25.1 ± 26.5 17.4 ± 23.0
PA6 S-2 4/10 (40) 7.3 ± 14.0 4.0 ± 7.4 10.8 ± 18.8 9.2 ± 17.8
1110007F12Rik 7/10 (70) 16.2 ± 14.8* 21.8 ± 26.3 18.7 ± 16.9 15.5 ± 16.7
1200009O22Rik 8/8 (100) 8.2 ± 10.2 14.5 ± 12.2 9.6 ± 13.4 8.3 ± 11.3
2900064A13Rik 2/5 (40) 3.3 ± 4.6 10.5 ± 20.6 3.6 ± 5.4 1.0 ± 2.2
Ccl9 2/5 (40) 11.1 ± 15.0 14.2 ± 19.5 12.7 ± 17.6 11.4 ± 15.7
IL-6 9/9 (100) 8.5 ± 13.5 8.1 ± 7.1 11.6 ± 16.9 9.2 ± 16.3
Ppap2b 8/10 (80) 9.7 ± 10.4 20.5 ± 26.7 9.2 ± 9.7 9.6 ± 14.6
Cxcl5 3/5 (60) 3.0 ± 4.0 12.8 ± 23.6 2.5 ± 3.5 1.9 ± 1.8
Thirty CD34
-KSL HSCs were cocultured with PA6 cells, PA6 S-2 cells, or PA6 S-2 cells expressing the indicated genes for 10 days and then
transplanted into lethally irradiated mice. At 16 weeks after transplantation, peripheral blood cells of the recipient mice were analyzed. Data
represent the mean ± SD
*P = 0.18 versus PA6 S-2, Student’s t-test
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1231200009O22Rik or IL-6 as well as with PA6 cells. How-
ever, comparison of the chimerism showed no signiﬁcant
differences from that of PA6 S-2 cells, suggesting that the
overexpression of neither 1200009O22Rik nor IL-6 com-
pletely restored the defective HSC-supporting activity of
PA6 S-2 cells. Microarray analysis showed that the
expression of IL-6 was approximately twofold up-regulated
in PA6 S-2 and S-12 cells when compared with OP9 cells;
this ﬁnding was conﬁrmed by quantitative real-time PCR
analysis (Table 3). It has also been demonstrated that IL-6
alone or in combination with SCF is incapable of main-
taining CD34
-KSL HSCs [8]. Although IL-6 is involved in
various steps of hematopoiesis and has been used for the ex
vivo expansion of HSCs [21], IL-6 may not be crucial for
the maintenance of HSCs governed by stromal cells.
PA6 S-2 cells overexpressing 2900064A13Rik or CCl9
had no apparent effect on the HSC-supporting activity. In
contrast, the overexpression of 1110007F12Rik, Ppap2b,
or Cxcl5 resulted in a certain increase in the frequency of
reconstituted mice. Although these genes as well as
1200009O22Rik and IL-6 could signiﬁcantly increase the
CFC frequency, the effect on the HSC-supporting activity
assessed by the competitive repopulation assay was lim-
ited. This may be because 10 days of coculture was not
long enough to detect a signiﬁcant difference in HSC-
supporting activity. It is of course well known that many
growth factors and cytokines that can increase the CFC
frequency have little inﬂuence on the maintenance and
proliferation of HSCs. Of note, the overexpression of
1110007F12Rik showed a substantial increase in the chi-
merism, although the difference did not reach statistical
signiﬁcance (Table 4). To conﬁrm the effect of
1110007F12Rik expression on the supportive activity of
PA6 cells, we performed the following experiments. First,
down-regulation of 1110007F12Rik expression in PA6 S-2
and S-12 cells compared to that in PA6 and OP9 cells was
conﬁrmed by quantitative real-time PCR analysis
(Table 3). Next, PA6 S-2 cells were transduced with a
myc-tagged 1110007F12Rik expression lentiviral vector
and its expression was detected by Western blotting and
immunoﬂuorescence staining with anti-myc antibody.
Coculture with PA6 S-2 cells overexpressing myc-tagged
1110007F12Rik resulted in an increase in the CFC fre-
quency at a level similar to that shown in Fig. 1 (data not
shown). The 1110007F12Rik cDNA encodes a predicted
protein of 185 amino acids, which is rich in leucine (23%)
and has no signiﬁcant homology with any known protein
sequences. 1110007F12Rik is also named as Tmem140
(transmembrane protein 140), which is predicted to be an
integral membrane protein gene according to the Gene
Ontology classiﬁcation. Further studies are required to
determine whether 1110007F12Rik is involved in the HSC-
supporting activity of PA6 cells.
Thus far, a large number of microarray analyses of
stromal cell lines derived from a variety of tissue types
have been reported. Comparison of gene expression pro-
ﬁles between HSC-supporting and HSC-nonsupporting
stromal cell lines has resulted in the identiﬁcation of a
number of differentially expressed genes [22]. In the
present study, we expected a few differences in gene
expression by comparing HSC-supporting PA6 cells with
HSC-nonsupporting PA6 subclone cells and indeed, we
could narrow down the candidate genes involved in
maintaining HSCs. Although one of the analyzed candidate
genes, 1110007F12Rik, demonstrated a partial restoration
of the defect in HSC-supporting activity of PA6 S-2 cells, it
is possible that other down-regulated genes in PA6 sub-
clone cells may also be required for the maintenance of
HSCs. Continuing studies to identify genes responsible for
HSC-supporting activity of PA6 cells would facilitate the
understanding of the mechanisms that control stem cell fate
through interaction with stromal cells.
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